CLOCK基因參與甲狀腺癌發(fā)生及進(jìn)展的生物學(xué)功能及分子機(jī)制研究
發(fā)布時(shí)間：2018-08-30 20:44
【摘要】：研究背景:甲狀腺癌是內(nèi)分泌系統(tǒng)最常見的惡性腫瘤之一,已成為國(guó)際上發(fā)病率增長(zhǎng)最快的實(shí)體瘤。臨床上用于甲狀腺癌早期篩查的指標(biāo)極為匱乏,亟待尋找新的分子標(biāo)志物。大量研究發(fā)現(xiàn)生物節(jié)律基因在大腸癌、乳腺癌等腫瘤的發(fā)生及進(jìn)展中發(fā)揮著重要作用。其中CLOCK、BMAL1、NPAS2三種生物節(jié)律基因的蛋白產(chǎn)物組成正性調(diào)控元件,驅(qū)動(dòng)生物節(jié)律的產(chǎn)生,并通過調(diào)控下游c-Myc、P53、P21等大量鐘控基因參與腫瘤細(xì)胞增殖、侵襲、轉(zhuǎn)移等重要功能,但生物節(jié)律基因在甲狀腺癌領(lǐng)域的研究較少。課題組前期通過免疫組化預(yù)實(shí)驗(yàn),發(fā)現(xiàn)甲狀腺乳頭狀癌組織中CLOCK基因表達(dá)升高。這些提示我們CLOCK基因在甲狀腺癌的發(fā)生及進(jìn)展中可能發(fā)揮重要作用,但其生物學(xué)作用及分子機(jī)制尚不清楚。目的:利用CLOCK基因siRNA干涉片段,下調(diào)甲狀腺癌細(xì)胞中CLOCK基因表達(dá)水平,分析干涉后甲狀腺癌細(xì)胞的生物學(xué)功能變化。并檢測(cè)P21、P53、CyclinD1等鐘控基因的表達(dá)變化,初步探討CLOCK基因參與甲狀腺癌發(fā)生及進(jìn)展的分子作用機(jī)制。方法:常規(guī)培養(yǎng)甲狀腺癌細(xì)胞株BCPAP,常規(guī)培養(yǎng)。根據(jù)CLOCK基因設(shè)計(jì)特異性的siRNA,利用Lipofecter 2000試劑轉(zhuǎn)染BCPAP細(xì)胞,將甲狀腺癌細(xì)胞株分為空白對(duì)照組(KD組),轉(zhuǎn)染試劑對(duì)照組(ZD組),單純siRNA對(duì)照組(SD),陰性對(duì)照組(YD組)和干涉組(GS組)5組。給予不同處理,利用Western Blot檢測(cè)干涉效率,CCK8實(shí)驗(yàn)檢測(cè)細(xì)胞增殖能力,粘附實(shí)驗(yàn)檢測(cè)細(xì)胞粘附能力,流式細(xì)胞儀檢測(cè)細(xì)胞凋亡程度,Transwell侵襲實(shí)驗(yàn)評(píng)估侵襲與轉(zhuǎn)移能力。并通過Western Blot檢測(cè)P21、P53、CyclinD1等分子在干涉CLOCK基因后的表達(dá)變化。結(jié)果:1.干涉組(GS組)BCPAP細(xì)胞增殖能力較空白對(duì)照組(GD組)降低(P0.05)。ZD組、SD組、YD組與GD組比無(wú)明顯改變(P0.05)。2.干涉組(GS組)BCPAP細(xì)胞凋亡較空白對(duì)照組(GD組)增多(P0.05)。ZD組、SD組、YD組與GD組比無(wú)明顯改變(P0.05)。3.干涉組(GS組)BCPAP細(xì)胞粘附能力較空白對(duì)照組(GD組)減低(P0.05)。ZD組、SD組、YD組與GD組比無(wú)明顯改變(P0.05)。4.干涉組(GS組)BCPAP遷移及侵襲細(xì)胞數(shù)較空白對(duì)照組(GD組)減少(P0.05)。ZD組、SD組、YD組與GD組比無(wú)明顯改變(P0.05)。5.P21、P53蛋白在干涉組(GS組)較空白對(duì)照組(GD組)升高(P0.05),CyclinD1蛋白在干涉組(GS組)較空白對(duì)照組(GD組)降低(P0.05)。結(jié)論:1.下調(diào)CLOCK基因的表達(dá)可以促進(jìn)甲狀腺癌細(xì)胞凋亡,抑制甲狀腺癌細(xì)胞增殖、浸潤(rùn)及轉(zhuǎn)移。2.CLOCK基因可能是通過調(diào)控甲狀腺癌細(xì)胞中P21、P53和CyclinD1重要基因的表達(dá),參與甲狀腺癌的發(fā)生及進(jìn)展。
[Abstract]:Background: thyroid carcinoma is one of the most common malignant tumors in the endocrine system. Clinical indicators for early screening of thyroid cancer are extremely scarce, so it is urgent to find new molecular markers. A large number of studies have found that biological rhythm genes play an important role in the occurrence and progression of colorectal cancer and breast cancer. The protein products of the three biological rhythm genes of CLOCK,BMAL1,NPAS2 constitute positive regulatory elements, which drive the production of biological rhythms, and participate in the important functions of tumor cell proliferation, invasion and metastasis by regulating a large number of clock control genes such as c-Myche P53, P21 and so on. However, biological rhythm genes in the field of thyroid cancer are less studied. We found that the expression of CLOCK gene in papillary thyroid carcinoma was higher than that in thyroid papillary carcinoma by immunohistochemistry. These results suggest that our CLOCK gene may play an important role in the carcinogenesis and progression of thyroid carcinoma, but its biological role and molecular mechanism are still unclear. Aim: to down-regulate the expression of CLOCK gene in thyroid cancer cells by siRNA interference fragment of CLOCK gene and analyze the biological function of thyroid cancer cells after intervention. The expression of P21, P53, CyclinD1 and other clock controlled genes was detected, and the molecular mechanism of CLOCK gene involved in the carcinogenesis and progression of thyroid carcinoma was preliminarily investigated. Methods: thyroid cancer cell line BCPAP, was cultured routinely. Thyroid cancer cells were transfected into BCPAP cells by Lipofecter 2000 reagent according to CLOCK gene design. Thyroid cancer cells were divided into five groups: blank control group (KD group), transfection reagent control group (ZD group), siRNA control group (SD), negative control group (YD group) and intervention group (GS group). Different treatments were used to detect the ability of cell proliferation by Western Blot and CCK8, and the degree of cell apoptosis by flow cytometry and the ability of invasion and metastasis by transwell invasion assay. The expression of P21, P53, CyclinD1 and other molecules were detected by Western Blot after interfering with CLOCK gene. The result is 1: 1. The proliferative ability of BCPAP cells in the intervention group (GS group) was lower than that in the blank control group (GD group) (P0.05). There was no significant difference between the SD group (P0.05) and the GD group (P0.05). 2. The apoptosis of BCPAP cells in the intervention group (GS group) was higher than that in the blank control group (GD group) (P0.05). The adhesion ability of BCPAP cells in the intervention group (GS group) was lower than that in the blank control group (GD group) (P0.05). There was no significant difference between the SD group and the GD group (P0.05). 4. The number of BCPAP migration and invasion cells in the intervention group (GS group) was lower than that in the blank control group (GD group) (P0.05). There was no significant change in the number of BCPAP migration and invasion cells between the SD group and the GD group in the ZD group (P0.05). The expression of p53 protein in the intervention group (GS group) was higher than that in the blank control group (GD group) (P0.05). The expression of CyclinD1 protein in the intervention group (GS group) was higher than that in the control group (P0.05). ) compared with the blank control group (GD group) decreased (P0.05). Conclusion 1. Down-regulating the expression of CLOCK gene can promote the apoptosis of thyroid cancer cells, inhibit the proliferation, invasion and metastasis of thyroid cancer cells. 2. CLOCK gene may regulate the expression of P21, p53 and CyclinD1 genes in thyroid cancer cells. Participate in the development and progression of thyroid carcinoma.
【學(xué)位授予單位】：蚌埠醫(yī)學(xué)院
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2016
【分類號(hào)】：R736.1
本文編號(hào)：2214241
[Abstract]:Background: thyroid carcinoma is one of the most common malignant tumors in the endocrine system. Clinical indicators for early screening of thyroid cancer are extremely scarce, so it is urgent to find new molecular markers. A large number of studies have found that biological rhythm genes play an important role in the occurrence and progression of colorectal cancer and breast cancer. The protein products of the three biological rhythm genes of CLOCK,BMAL1,NPAS2 constitute positive regulatory elements, which drive the production of biological rhythms, and participate in the important functions of tumor cell proliferation, invasion and metastasis by regulating a large number of clock control genes such as c-Myche P53, P21 and so on. However, biological rhythm genes in the field of thyroid cancer are less studied. We found that the expression of CLOCK gene in papillary thyroid carcinoma was higher than that in thyroid papillary carcinoma by immunohistochemistry. These results suggest that our CLOCK gene may play an important role in the carcinogenesis and progression of thyroid carcinoma, but its biological role and molecular mechanism are still unclear. Aim: to down-regulate the expression of CLOCK gene in thyroid cancer cells by siRNA interference fragment of CLOCK gene and analyze the biological function of thyroid cancer cells after intervention. The expression of P21, P53, CyclinD1 and other clock controlled genes was detected, and the molecular mechanism of CLOCK gene involved in the carcinogenesis and progression of thyroid carcinoma was preliminarily investigated. Methods: thyroid cancer cell line BCPAP, was cultured routinely. Thyroid cancer cells were transfected into BCPAP cells by Lipofecter 2000 reagent according to CLOCK gene design. Thyroid cancer cells were divided into five groups: blank control group (KD group), transfection reagent control group (ZD group), siRNA control group (SD), negative control group (YD group) and intervention group (GS group). Different treatments were used to detect the ability of cell proliferation by Western Blot and CCK8, and the degree of cell apoptosis by flow cytometry and the ability of invasion and metastasis by transwell invasion assay. The expression of P21, P53, CyclinD1 and other molecules were detected by Western Blot after interfering with CLOCK gene. The result is 1: 1. The proliferative ability of BCPAP cells in the intervention group (GS group) was lower than that in the blank control group (GD group) (P0.05). There was no significant difference between the SD group (P0.05) and the GD group (P0.05). 2. The apoptosis of BCPAP cells in the intervention group (GS group) was higher than that in the blank control group (GD group) (P0.05). The adhesion ability of BCPAP cells in the intervention group (GS group) was lower than that in the blank control group (GD group) (P0.05). There was no significant difference between the SD group and the GD group (P0.05). 4. The number of BCPAP migration and invasion cells in the intervention group (GS group) was lower than that in the blank control group (GD group) (P0.05). There was no significant change in the number of BCPAP migration and invasion cells between the SD group and the GD group in the ZD group (P0.05). The expression of p53 protein in the intervention group (GS group) was higher than that in the blank control group (GD group) (P0.05). The expression of CyclinD1 protein in the intervention group (GS group) was higher than that in the control group (P0.05). ) compared with the blank control group (GD group) decreased (P0.05). Conclusion 1. Down-regulating the expression of CLOCK gene can promote the apoptosis of thyroid cancer cells, inhibit the proliferation, invasion and metastasis of thyroid cancer cells. 2. CLOCK gene may regulate the expression of P21, p53 and CyclinD1 genes in thyroid cancer cells. Participate in the development and progression of thyroid carcinoma.
【學(xué)位授予單位】：蚌埠醫(yī)學(xué)院
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2016
【分類號(hào)】：R736.1
【參考文獻(xiàn)】
相關(guān)期刊論文 前9條
1 龔巍巍;胡如英;羅勝蘭;潘勁;費(fèi)方榮;何青方;張智童;俞敏;;浙江省2007—2011年甲狀腺癌發(fā)病及死亡特征分析[J];浙江預(yù)防醫(yī)學(xué);2014年05期
2 沈永洲;沈高飛;祝麗娟;;海寧市1977-2010年甲狀腺癌發(fā)病趨勢(shì)分析[J];中國(guó)慢性病預(yù)防與控制;2012年02期
3 駱華杰;李吉平;楊騰飛;王家東;;VEGF-C和VEGF-D在分化型甲狀腺癌中的表達(dá)及意義[J];臨床耳鼻咽喉頭頸外科雜志;2009年12期
4 倪銀華;吳濤;王露;夏李群;張丹萍;傅正偉;;腎上腺糖皮質(zhì)激素與生物鐘基因表達(dá)調(diào)控的相關(guān)研究進(jìn)展[J];遺傳;2008年02期
5 王艷紅;文勇立;齊莎日娜;孫靜;楊雪;邱翔;陳雪梅;;哺乳動(dòng)物生物鐘模型及研究進(jìn)展[J];四川生理科學(xué)雜志;2006年01期
6 周梅;趙剛;黎音;;cyclinE、P~(21WAF1/CIP1)及MMP-2蛋白在甲狀腺癌中的表達(dá)及意義[J];新疆醫(yī)學(xué);2005年05期
7 姜漢國(guó),高嵋,唐慰萍,李飛虹,蔡瓊珍;VEGF、VEGF-C和VEGF-D在甲狀腺乳頭狀癌組織中的表達(dá)及意義[J];癌癥;2005年09期
8 陳紅兵,羅好曾,馬有國(guó);武威市甲狀腺癌發(fā)病率對(duì)比分析[J];中國(guó)腫瘤;2004年05期
9 趙軍,霍雄偉,蘇清華,馬建倉(cāng),李曉斌;P53與P21(WAF1/CIP1)在甲狀腺癌中的表達(dá)及臨床意義[J];西安醫(yī)科大學(xué)學(xué)報(bào)(中文版);2000年03期
，本文編號(hào)：2214241
本文鏈接：http://www.sikaile.net/kejilunwen/jiyingongcheng/2214241.html
最近更新
教材專著
